US2022120649A1PendingUtilityA1

Ligand-functionalized substrates with enhanced binding capacity

Assignee: 3M INNOVATIVE PROPERTIES COPriority: Oct 3, 2013Filed: Dec 27, 2021Published: Apr 21, 2022
Est. expiryOct 3, 2033(~7.2 yrs left)· nominal 20-yr term from priority
B01D 71/44B01D 67/00931B01D 71/521B01D 2325/14B01J 20/261B01D 2325/16C07F 9/38B01J 20/3242C07F 5/04B01J 20/327C07F 5/02B01D 2323/345G01N 1/4077C07K 1/34G01N 2333/924C07F 9/3808B01D 71/56G01N 33/544G01N 2001/4088C08J 2377/00C08J 7/18B01J 20/321C07K 1/18B01J 20/3253B01J 20/28038B01D 2323/38G01N 1/405B01J 20/3251C07F 5/00B01D 67/0093B01D 71/52
79
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An article that can be used for biomaterial capture comprises(a) a porous substrate; and(b) borne on the porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to the monovalent groups so as to link at least one ethylenically unsaturated group and at least one ligand functional group by a chain of at least six catenated atoms.

Claims

exact text as granted — not AI-modified
1 .- 23 . (canceled) 
     
     
         24 . A method of preparing a crosslinked, porous particle, the method comprising:
 forming an aqueous phase monomer mixture comprising:
 (a) a crosslinking monomer; and 
 (b) at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to said monovalent groups so as to link at least one said ethylenically unsaturated group and at least one said ligand functional group by a chain of at least six catenated atoms; 
   suspending the aqueous phase monomer mixture in a non-polar solvent; and   polymerizing the monomer mixture to form particles comprising the ligand functional group.   
     
     
         25 . The method of  claim 24 , wherein the aqueous phase monomer mixture further comprises a third comonomer. 
     
     
         26 . The method of  claim 24 , wherein the aqueous phase monomer mixture further comprises a porogen. 
     
     
         27 . The method of  claim 25 , wherein the aqueous phase monomer mixture further comprises a porogen. 
     
     
         28 . A method of preparing a crosslinked, porous particle, said method comprising:
 forming an aqueous phase monomer mixture comprising:
 (a) a crosslinking monomer; and 
 (b) a monomer of Formula I
   CH 2 ═CR 1 —C(═O)—X—R 2 —[Z—R 2 ] n -L  (I)
 
 
   wherein
 R 1  is selected from hydrogen, alkyl, cycloalkyl, aryl, and combinations thereof; 
 each R 2  is independently selected from hydrocarbylene, heterohydrocarbylene, and combinations thereof; 
 X is —O— or —NR 3 —, where R 3  is selected from hydrogen, hydrocarbyl, heterohydrocarbyl, and combinations thereof; 
 Z is heterohydrocarbylene comprising at least one hydrogen bond donor, at least one hydrogen bond acceptor, or a combination thereof; 
   n is an integer of 0 or 1; and
 L is a heteroatom-containing group comprising at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof; 
   suspending the aqueous phase monomer mixture in a non-polar solvent; and   polymerizing the monomer mixture to form particles comprising the ligand functional group.   
     
     
         29 . The method of  claim 28 , wherein the aqueous phase monomer mixture further comprises a third comonomer. 
     
     
         30 . The method of  claim 28 , wherein the aqueous phase monomer mixture further comprises a porogen. 
     
     
         31 . The method of  claim 29 , wherein the aqueous phase monomer mixture further comprises a porogen. 
     
     
         32 . A method of preparing a substrate bearing a crosslinked coating, the method comprising:
 forming an aqueous phase monomer mixture comprising:
 (a) a crosslinking monomer; and 
 (b) at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to said monovalent groups so as to link at least one said ethylenically unsaturated group and at least one said ligand functional group by a chain of at least six catenated atoms; 
   providing a porous substrate;   coating the aqueous phase monomer mixture on the substrate; and   polymerizing the monomer mixture to form a coating on the substrate comprising the ligand functional group.   
     
     
         33 . The method of  claim 32 , wherein the porous substrate is selected from the group consisting of porous particles, porous membranes, porous nonwoven webs, porous woven webs, porous sponges, porous fibers, and combinations thereof.

Join the waitlist — get patent alerts

Track US2022120649A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.